Closing Bell: Best Bull Market Opportunities 9/24/24
Closing Bell
Debate on Weight Loss Drug Prices and Healthcare System Issues
This chapter explores the controversy surrounding the steep costs of weight loss medications like Ozempic and Wigovi, featuring testimony from the CEO of Novo Nordisk. It highlights public frustration over pharmaceutical profits and the implications for the U.S. healthcare system.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
